IL1A and Alzheimer disease: As shown in Fig. 5c, YU102 treatment led to significantly decreased serum levels of IL-1α in Tg2576 mice compared to vehicle controls, suggesting that YU102 may contribute to suppressing inflammatory responses in the mouse model of AD.